← Back
$RAPP All transactions

Rapport Therapeutics, Inc.

▲ BUY
8 / 10

Conviction

$ Value

$693K

Shares

28,284

Price

$24

Filed

Sep 15

Why this score? (8/10)
  • Open market buy (+3)
  • Trade value >= $250K (+1)
  • Director (+1)
  • Cluster: 3 insiders buying (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

PAUL STEVEN M

Title

CIK

0001237564

Roles

Director

Transaction Details

Transaction Date

2025-09-12

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

28,284

Footnotes

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $23.90 to $24.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected. | Shares held by Paul Capital Strategy III Fund LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any. | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $24.90 to $25.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.

Filing Info

Accession No.

0001193125-25-203537

Form Type

4

Issuer CIK

0002012593

PAUL STEVEN M's History

Date Ticker Type Value
2025-09-12 RAPP $693K
2025-09-12 RAPP $334K
2025-06-17 RAPP A $0

Other Insiders at RAPP (90d)

Insider Bought Sold Last
Third Rock Ventures V, L.P. $17.2M 2026-04-17
Gault Cheryl
Chief Operating Officer
$282K 2026-03-30
Yeleswaram Krishnaswamy
Chief Development Officer
$1.8M 2026-04-17